Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2004 Feb;101(2):153-7.
doi: 10.1007/s00347-003-0894-z.

[Vitreoretinal traction syndrome in multiple sclerosis]

[Article in German]
Affiliations
Case Reports

[Vitreoretinal traction syndrome in multiple sclerosis]

[Article in German]
A Hochwarter et al. Ophthalmologe. 2004 Feb.

Abstract

Methods: From January to December 2001, 89 patients with multiple sclerosis (MS) were treated in our hospital; 24 of them were diagnosed for the first time. All patients underwent a complete ophthalmologic examination including a three-mirror contact lens examination when photopsias were found or the disease was diagnosed primarily.

Results: Two patients showed vitreoretinal tractions with signs of periphlebitis before clinical-neurological manifestation of multiple sclerosis. The third patient, in whom the disease had been known for years, showed distinct neovascularizations, vasculitis, and recurrent vitreous hemorrhages. High-dose steroid therapy resulted in stabilization of the retinal situation in one patient, but the tractions remained unchanged. Additional laser coagulation in the second patient achieved stabilization and reduction of the tractions. A pars plana vitrectomy led to stabilization of the retinal proliferation in the third patient.

Conclusions: The vitreoretinal traction syndrome is associated with MS and can precede its clinical-neurological manifestation. The good results after argon laser coagulation and vitreoretinal surgery suggest a vascular pathogenesis of these tractions.

PubMed Disclaimer

References

    1. Neurologia. 1993 Oct;8(8):252-5 - PubMed
    1. Ger J Ophthalmol. 1995 Nov;4(6):328-31 - PubMed
    1. Int Ophthalmol Clin. 2001 Winter;41(1):41-59 - PubMed
    1. Acta Ophthalmol (Copenh). 1985 Feb;63(1):80-2 - PubMed
    1. Dev Ophthalmol. 1992;23:99-105 - PubMed

MeSH terms

LinkOut - more resources